Annual report pursuant to Section 13 and 15(d)

SEGMENTS (Tables)

v3.21.1
SEGMENTS (Tables)
12 Months Ended
Dec. 31, 2020
SEGMENTS  
Summarized segment financial information

Year Ended December 31, 2020

 

 

ADMA BioManufacturing

 

 

Plasma Collection Centers

 

 

Corporate

 

 

Consolidated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$ 36,673,287

 

 

$ 5,403,662

 

 

$ 142,834

 

 

$ 42,219,783

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of product revenue

 

 

55,908,696

 

 

 

5,382,730

 

 

 

-

 

 

 

61,291,426

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

(46,904,634 )

 

 

(4,410,890 )

 

 

(13,599,353 )

 

 

(64,914,877 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest and other expense, net

 

 

(984,017 )

 

 

(7,388 )

 

 

(10,834,063 )

 

 

(11,825,468 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gain on extinguishment of debt

 

 

-

 

 

 

-

 

 

 

991,797

 

 

 

991,797

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

 

(47,888,651 )

 

 

(4,418,278 )

 

 

(23,441,619 )

 

 

(75,748,548 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Capital expenditures

 

 

7,579,437

 

 

 

5,147,243

 

 

 

-

 

 

 

12,726,680

 

Depreciation and amortization expense

 

 

3,341,506

 

 

 

591,593

 

 

 

9,193

 

 

 

3,942,292

 

Total assets

 

 

140,908,957

 

 

 

13,102,008

 

 

 

53,662,429

 

 

 

207,673,394

 

 

Year Ended December 31, 2019

 

 

ADMA BioManufacturing

 

 

Plasma Collection Centers

 

 

Corporate

 

 

Consolidated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$ 22,176,699

 

 

$ 7,029,550

 

 

$ 142,834

 

 

$ 29,349,083

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of product revenue

 

 

33,306,858

 

 

 

6,197,380

 

 

 

-

 

 

 

39,504,238

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

(29,360,522 )

 

 

(1,337,459 )

 

 

(10,726,346 )

 

 

(41,424,327 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest and other expense, net

 

 

(1,091,993 )

 

 

13,521

 

 

 

(7,341,444 )

 

 

(8,419,916 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gain on transfer of plasma center assets

 

 

-

 

 

 

11,527,421

 

 

 

-

 

 

 

11,527,421

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss on extinguishment of debt

 

 

-

 

 

 

-

 

 

 

(9,962,495 )

 

 

(9,962,495 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income

 

 

(30,452,515 )

 

 

10,203,483

 

 

 

(28,030,285 )

 

 

(48,279,317 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Capital expenditures

 

 

3,772,742

 

 

 

39,096

 

 

 

-

 

 

 

3,811,838

 

Depreciation and amortization expense

 

 

2,789,498

 

 

 

455,412

 

 

 

13,238

 

 

 

3,258,148

 

Total assets

 

 

100,461,050

 

 

 

3,967,860

 

 

 

22,661,815

 

 

 

127,090,725